Literature DB >> 3659434

[An "atraumatic" universal needle for single-shot regional anesthesia: clinical results and a 6 year trial in over 30,000 regional anesthesias].

G Sprotte1, R Schedel, H Pajunk, H Pajunk.   

Abstract

The so-called "atraumatic" needle was developed by modification of two essential features of the Whitacre Spinal needle. The new atraumatic needle tip is universally suitable for all single-shot techniques of regional anesthesia. This is the result of a 6-year test period with 34,950 applications of 24- and 22-Gauge needles in spinal anesthesia, diagnostic lumbar puncture, peridural anesthesia, plexus anesthesia, peripheral nerve blocks with a Teflon-coated version (unipolar electrostimulation), and lumbar sympathetic and celiac plexus blocks. Postspinal headache was observed following 0.02% of punctures for anesthetic or diagnostic purposes. Transient monosymptomatic nerve damage occurred in 1 case after axillary block (0.009%). No permanent neurological sequelae were observed due to vascular, neural, or dural lesions. In comparison, 10 cases of persistent traumatic nerve damage were reported to be caused by conventional needles during the last decade. An analysis of these cases reveals some reasons for underestimating the risk of neurological sequelae after regional anesthesia. The routine clinical use of this type of atraumatic needle revealed no disadvantages with regard to efficacy of nerve blocks or training of anesthetists. Due to the extremely low incidence of postspinal headache, this needle has been used for spinal therapy and diagnostic lumbar punctures in outpatient pain therapy for 2 years. As of this time, the overall risk of outpatient lumbar puncture cannot be estimated. Our experience should encourage further controlled studies to evaluate criteria for excluding those patients unsuited for outpatient spinal anesthesia and lumbar puncture.

Entities:  

Mesh:

Year:  1987        PMID: 3659434

Source DB:  PubMed          Journal:  Reg Anaesth        ISSN: 0171-1946


  13 in total

1.  Abducens palsy following spinal anesthesia: mechanism, treatment, and anesthetic considerations.

Authors:  Sadeq A Quraishi
Journal:  MedGenMed       Date:  2005-10-17

2.  Postlumbar puncture headache.

Authors:  K V Toyka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  Analgesia methods during labour and delivery.

Authors:  S C Hughes
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

4.  [An atraumatic needle for the puncture of ports and pumps].

Authors:  H Haindl; H Müller
Journal:  Klin Wochenschr       Date:  1988-10-17

5.  Comparison of sprotte and Quincke needles with respect to spinal fluid leakage using artificial spinal cord.

Authors:  Yoshikiyo Amaki; Michihiko Moriyama; Toshimichi Kuzuta; Keiko Yabe; Misato Kaneko
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

6.  A directional needle improves effectiveness and reduces complications of microcatheter continuous spinal anaesthesia.

Authors:  T Standl; S Eckert; I Rundshagen; J Schulte am Esch
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

Review 7.  Labour analgesia. A risk-benefit analysis.

Authors:  R L Eberle; M C Norris
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

8.  Postdural puncture headache: a randomized prospective comparison of the 24 gauge Sprotte and the 27 gauge Quincke needles in young patients.

Authors:  S Wiesel; M J Tessler; L J Easdown
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

9.  Atraumatic needle reduces the incidence of post-lumbar puncture syndrome.

Authors:  B Müller; K Adelt; H Reichmann; K Toyka
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

10.  Comparison of the 25-gauge Whitacre with the 24-gauge Sprotte spinal needle for elective caesarean section: cost implications.

Authors:  D C Campbell; M J Douglas; T J Pavy; P Merrick; M L Flanagan; G H McMorland
Journal:  Can J Anaesth       Date:  1993-12       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.